Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neurocrine Bioscienc (NQ: NBIX ) 133.62 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 133.62 Bid (Size) 131.01 (1) Ask (Size) 141.32 (1) Prev. Close 133.62 Today's Range 133.62 - 133.62 52wk Range 93.02 - 148.37 Shares Outstanding 100,600,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Despite its impressive fundamentals, NASDAQ:NBIX remains undervalued. June 20, 2024 NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX), an undervalued stock with good fundamentals. Via Chartmill 7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline June 17, 2024 With biotech stocks enjoying a permanently relevant narrative, investors should focus on these compelling opportunities. Via InvestorPlace Performance YTD +1.43% +1.43% 1 Month -4.88% -4.88% 3 Month -4.73% -4.73% 6 Month +1.85% +1.85% 1 Year +39.06% +39.06% More News Read More Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock? June 14, 2024 Via Chartmill Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans June 14, 2024 Via Investor's Business Daily Don't overlook NASDAQ:NBIX—a stock with solid growth prospects and a reasonable valuation. June 13, 2024 Via Chartmill Key Takeaways From Neurocrine Biosciences Analyst Ratings May 28, 2024 Via Benzinga Exploring NASDAQ:NBIX's quality characteristics. May 27, 2024 Via Chartmill Exploring the Growth Potential of NASDAQ:NBIX as It Nears a Breakout. May 24, 2024 Via Chartmill In the world of growth stocks, NASDAQ:NBIX shines as a value proposition. May 23, 2024 Via Chartmill Nvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam May 04, 2024 Via Investor's Business Daily A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation May 03, 2024 Via Investor's Business Daily Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review May 03, 2024 Via Investor's Business Daily Topics Economy Exposures Interest Rates Why Quality Investors May Find NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Attractive. May 03, 2024 Via Chartmill NASDAQ:NBIX, a strong growth stock, setting up for a breakout. May 02, 2024 Via Chartmill Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences May 01, 2024 Via Benzinga Despite its growth, NASDAQ:NBIX remains within the realm of affordability. May 02, 2024 Via Chartmill PTC Therapeutics Stock Sees IBD RS Rating Climb To 72 May 01, 2024 Via Investor's Business Daily NBIX Stock Earnings: Neurocrine Biosciences Beats EPS, Beats Revenue for Q1 2024 May 01, 2024 Via InvestorPlace No. 1 Biotech Stock Neurocrine Pops After Its Biggest Moneymaker Snatches Another Win May 01, 2024 Via Investor's Business Daily Sarepta Therapeutics Stock Shows Improved Technical Strength April 29, 2024 Via Investor's Business Daily Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review April 26, 2024 Via Investor's Business Daily 3 Red-Hot Biotech Rockets Blasting Off in 2024 April 24, 2024 Via InvestorPlace Topics Economy Exposures Economy Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder April 23, 2024 Via Benzinga No. 1 Biotech Stock Neurocrine Launches Higher On Depression Treatment Win April 23, 2024 Via Investor's Business Daily Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides April 16, 2024 From Sentia Medical Sciences, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
